Vaccine News and Research

Latest Vaccine News and Research

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Exciting findings on CD8 T cell response in recovered COVID patients

An international team of scientists has identified novel T cell-recognized epitopes spanning different proteins of severe acute respiratory syndrome coronavirus 2 in COVID-19 recovered patients. The scientists have also revealed phenotypical characteristics of the T cell population.

11 Oct 2020

CHLA investigator receives $3.4 million research grant to study rotavirus vaccine

Rotavirus (RV) is an extremely contagious viral infection and the most common cause of diarrhea in infants and children worldwide.

9 Oct 2020

New initiative identifies key parameters underlying effective anti-tumor immunity

Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.

9 Oct 2020

Launch of new WHO guidance on ethics and vector-borne diseases

On Wednesday 14 October, WHO will launch new guidance: Ethics & vector-borne diseases. The guidance document is a culmination of more than three years of work and will be a valuable new tool to support global efforts to prevent and control vector-borne diseases (VBDs).

9 Oct 2020

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.

9 Oct 2020

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging.

9 Oct 2020

Serum antibodies from SARS-CoV patients effectively neutralized SARS-CoV-2 in cultured cells

Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.

9 Oct 2020

Communication with trial participants, communities is key to finding a successful vaccine

Communication with COVID-19 vaccine trial participants and their communities, pre, during and post-trial is key to finding and delivering a successful vaccine, say social scientists from the Social Science in Humanitarian Action Platform, in a new brief published today.

9 Oct 2020

Findings could bring hope for novel therapeutic strategies against malaria

The Plasmodium parasite, which transmits malaria to humans through infected mosquitos, triggers changes in human genes that alter the body's adaptive immune response to malarial infections, according to a team of researchers at NYU Abu Dhabi (NYUAD).

9 Oct 2020

People’s trust in media is associated with COVID-19 prevention behaviors

Whether someone wears a mask, practices physical distancing or performs other behaviors to prevent COVID-19 infection may be linked to what media outlets they trust.

9 Oct 2020

University of Minnesota Medical School chosen as ‘Capacity Building Center’ for national network

The University of Minnesota Medical School's Department of Laboratory Medicine and Pathology has been selected to participate in a new national network dedicated to serological, or antibody, sciences as one of four Capacity Building Centers in the country.

9 Oct 2020

Clear and unequivocal evidence we should washing our hands during COVID-19

The study shows that Americans are washing their hands much more they did before the coronavirus pandemic. However, the groups who are less likely to remember to wash their hands on multiple occasions were white people, men, and those between the ages of 18 and 24.

9 Oct 2020

Mass production of SARS-CoV-2 ORF8 protein using a chemical-inducible system in tobacco BY-2 cells

Researchers from the Japan Advanced Institute of Science and Technology (JAIST) and Ishikawa Prefectural University, Japan, recently attempted to synthesize the ORF8 protein with the help of a chemical-inducible protein production system using tobacco BY-2 cells. This study has been published demonstrated in the preprint server, bioRxiv.

9 Oct 2020

Mount Sinai to receive more than $7.3 million as part of NCI's new Serological Sciences Network

Researchers from the Icahn School of Medicine at Mount Sinai will receive more than $7.3 million from the National Cancer Institute as part of the NCI's new Serological Sciences Network (SeroNet), one of the largest coordinated national efforts to study immunology and SARS-CoV-2, the virus that causes COVID-19.

8 Oct 2020

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from the virus.

8 Oct 2020

NIH clinical trial to test a combination treatment regimen for COVID-19

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.

8 Oct 2020

In debate, Pence and Harris offer conflicting views of nation’s reality

The Trump administration's pandemic response: decisive action that saved lives, or the greatest failure of any presidential administration? During Wednesday's vice presidential debate, Vice President Mike Pence and the Democratic challenger, Sen. Kamala Harris of California, offered drastically different takes — from behind plexiglass screens — on how the president has handled the COVID-19 crisis.

8 Oct 2020

Neutralizing responses to infection relatively common in COVID-19

A new study has shown that severe coronavirus disease 2019 (COVID-19) is associated with unique B cell receptor (BCR) signatures and multiclonal neutralizing responses against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Oct 2020

Leopoldina appeals to governments to take protective measures on COVID-19 pandemic

Since the end of July, the number of new infections with the coronavirus has been on the rise again in Germany.

8 Oct 2020

Vaccine News and Research

Latest Vaccine News and Research

Analysis of existing comorbidities and COVID-19 mortality

Exciting findings on CD8 T cell response in recovered COVID patients

CHLA investigator receives $3.4 million research grant to study rotavirus vaccine

New initiative identifies key parameters underlying effective anti-tumor immunity

Launch of new WHO guidance on ethics and vector-borne diseases

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

Serum antibodies from SARS-CoV patients effectively neutralized SARS-CoV-2 in cultured cells

Communication with trial participants, communities is key to finding a successful vaccine

Findings could bring hope for novel therapeutic strategies against malaria

People’s trust in media is associated with COVID-19 prevention behaviors

University of Minnesota Medical School chosen as ‘Capacity Building Center’ for national network

Clear and unequivocal evidence we should washing our hands during COVID-19

Mass production of SARS-CoV-2 ORF8 protein using a chemical-inducible system in tobacco BY-2 cells

Mount Sinai to receive more than $7.3 million as part of NCI's new Serological Sciences Network

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

NIH clinical trial to test a combination treatment regimen for COVID-19

In debate, Pence and Harris offer conflicting views of nation’s reality

Neutralizing responses to infection relatively common in COVID-19

Leopoldina appeals to governments to take protective measures on COVID-19 pandemic

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Newsletters you may be interested in